Free Trial

HUTCHMED (HCM) Competitors

HUTCHMED logo
GBX 260 +21.00 (+8.79%)
As of 12:18 PM Eastern

HCM vs. SOPH, ITH, INDV, GRI, SLS, ERGO, SLN, AMYT, BMY, and GPH

Should you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Sophos Group plc (SOPH.L) (SOPH), Ithaca Energy (ITH), Indivior (INDV), Grainger (GRI), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Silence Therapeutics (SLN), Amryt Pharma (AMYT), Bloomsbury Publishing (BMY), and Global Ports (GPH). These companies are all part of the "pharmaceutical products" industry.

HUTCHMED vs. Its Competitors

Sophos Group plc (SOPH.L) (LON:SOPH) and HUTCHMED (LON:HCM) are both mid-cap pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

Sophos Group plc (SOPH.L) has higher revenue and earnings than HUTCHMED. Sophos Group plc (SOPH.L) is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sophos Group plc (SOPH.L)£726.90M0.00N/A£1.70N/A
HUTCHMED£602.20M3.71-£52.98M£0.53490.57

In the previous week, HUTCHMED had 2 more articles in the media than Sophos Group plc (SOPH.L). MarketBeat recorded 2 mentions for HUTCHMED and 0 mentions for Sophos Group plc (SOPH.L). HUTCHMED's average media sentiment score of 0.73 beat Sophos Group plc (SOPH.L)'s score of 0.00 indicating that HUTCHMED is being referred to more favorably in the news media.

Company Overall Sentiment
Sophos Group plc (SOPH.L) Neutral
HUTCHMED Positive

2.2% of HUTCHMED shares are held by institutional investors. 2.8% of HUTCHMED shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Sophos Group plc (SOPH.L) has a net margin of 0.00% compared to HUTCHMED's net margin of -6.87%. Sophos Group plc (SOPH.L)'s return on equity of 0.00% beat HUTCHMED's return on equity.

Company Net Margins Return on Equity Return on Assets
Sophos Group plc (SOPH.L)N/A N/A N/A
HUTCHMED -6.87%-5.71%-5.90%

Summary

Sophos Group plc (SOPH.L) and HUTCHMED tied by winning 5 of the 10 factors compared between the two stocks.

Get HUTCHMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HCM vs. The Competition

MetricHUTCHMEDDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£2.23B£1.68B£5.79B£2.58B
Dividend Yield4.63%2.93%5.69%5.30%
P/E Ratio490.5765.3974.595,410.66
Price / Sales3.711,297.60453.5496,691.07
Price / Cash2.4910.3737.0827.93
Price / Book2.9711.9112.157.76
Net Income-£52.98M£20.70B£3.28B£5.89B
7 Day Performance10.64%0.81%0.99%6.49%
1 Month Performance16.59%3.44%7.21%56.20%
1 Year Performance1.96%4.80%63.07%148.15%

HUTCHMED Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCM
HUTCHMED
N/AGBX 260
+8.8%
N/A-5.5%£2.23B£602.20M490.571,760News Coverage
Positive News
Gap Up
High Trading Volume
SOPH
Sophos Group plc (SOPH.L)
N/AN/AN/AN/A£2.99B£726.90M341.41520
ITH
Ithaca Energy
N/AGBX 181.40
-2.3%
N/A+88.2%£2.99B£2.59B-1,711.32220Gap Down
INDV
Indivior
2.1233 of 5 stars
GBX 1,238
+1.6%
GBX 1,800
+45.4%
+72.4%£1.93B£1.40B-1,026.481,000Gap Up
High Trading Volume
GRI
Grainger
3.4488 of 5 stars
GBX 190.20
+0.1%
GBX 317.50
+66.9%
-19.2%£1.40B£306.10M1,293.88372Dividend Increase
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
BMY
Bloomsbury Publishing
2.3032 of 5 stars
GBX 495
-0.3%
GBX 825
+66.7%
-22.5%£403.32M£361M1,611.8534,300Positive News
GPH
Global Ports
N/AN/AN/AN/A£231.21M£193.58M30,000.0020

Related Companies and Tools


This page (LON:HCM) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners